|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,483.40 INR | +2.69% |
|
+4.80% | -1.87% |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
| 07-24 | Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform | MT |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- CIPLA Stock
- News Cipla Limited
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions

















